US stock · Healthcare sector · Pharmaceutical Retailers
Company Logo

Walgreens Boots Alliance, Inc.

WBANASDAQ

36.28

USD
-0.81
(-2.18%)
Pre Market
7.21P/E
8Forward P/E
0.33P/E to S&P500
31.292BMarket CAP
5.16%Div Yield
Upcoming Earnings
29 Mar-3 Apr
Shares Short
1/13/23
32.79M
Short % of Float
4.59%
Short % of Shares Outs.
3.80%
% Held by Insiders
17.19%
% Held by Institutions
61.10%
Beta
0.74
PEG Ratio
3.58
52w. high/low
50.19/30.39
Avg. Daily Volume
6.37M
Return %
Stock
S&P 500
1 year
(25.81)
(8.58)
3 years
(31.97)
23.39
5 years
- -
- -
Scale: |
High
Low
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
86.31
59.07
74.94
49.03
59.78
33.36
57.05
39.94
55.00
30.39
37.95
34.30
Currency: USD
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
Revenue per share
53.84
59.59
63.97
68.68
78.88
81.89
76.34
80.15
99.16
108.35
110.12
132.73
148.53
158.67
153.23
153.52
153.01
Earnings per share
2.04
2.18
2.03
2.13
2.97
2.43
2.59
2.03
4.05
3.85
3.80
5.07
4.32
0.52
2.94
5.02
(3.99)
FCF per share
0.57
0.82
2.21
2.78
2.66
3.29
3.27
2.92
4.23
6.02
5.50
6.96
4.22
4.67
4.83
2.50
1.62
Dividends per share
0.31
0.38
0.45
0.55
0.71
0.90
1.10
1.26
1.33
1.44
1.61
1.75
1.78
1.99
1.87
1.92
1.92
CAPEX per share
1.79
2.25
1.95
1.03
1.33
1.77
1.28
1.16
1.20
1.22
1.26
1.38
1.85
1.56
1.59
2.01
2.19
Book Value per sh.
11.12
12.99
14.52
14.67
16.22
20.85
20.56
21.46
29.58
27.59
25.59
26.24
25.51
23.47
27.08
33.97
30.94
Comm.Shares outs.
999
991
990
982
915
875
946
953
1,043
1,083
1,074
991
922
879
865
864
864
Avg. annual P/E ratio
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
13.7
13.6
82.5
17.0
8.3
7.2
P/E to S&P500
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.5
0.6
2.2
0.6
0.4
0.3
Avg. annual div. yield
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2.5%
3.0%
4.6%
3.7%
4.6%
5.0%
Revenue (m)
53,762
59,034
63,335
67,420
72,184
71,633
72,217
76,392
103,444
117,351
118,214
131,537
136,866
139,537
132,509
132,703
132,184
Operating margin
5.9%
5.8%
5.1%
5.1%
6.0%
4.8%
5.5%
5.5%
4.5%
5.1%
4.7%
4.9%
3.7%
0.9%
1.8%
1.0%
(4.6)%
Depreciation (m)
676
840
975
1,030
1,086
1,166
1,283
1,316
1,742
1,718
1,654
1,770
2,038
1,927
1,973
1,990
1,985
Net profit (m)
2,041
2,157
2,006
2,091
2,714
2,127
2,450
1,932
4,220
4,173
4,078
5,024
3,982
456
2,542
4,337
(3,436)
Income tax rate
36.0%
37.1%
36.6%
38.0%
36.8%
37.0%
37.1%
42.9%
19.9%
19.4%
15.7%
16.7%
13.0%
48.5%
33.4%
0.7%
324.6%
Net profit margin
3.8%
3.7%
3.2%
3.1%
3.8%
3.0%
3.4%
2.5%
4.1%
3.6%
3.4%
3.8%
2.9%
0.3%
1.9%
3.3%
(2.6)%
Working capital (m)
2,766
3,790
5,280
4,489
4,239
2,038
2,991
3,347
3,100
8,870
1,206
(3,821)
(7,069)
(8,997)
(6,240)
(5,681)
(8,513)
Long-term debt (m)
- -
1,337
2,336
2,389
2,396
4,073
4,477
3,736
13,315
18,705
12,684
12,431
11,098
12,203
29,828
32,132
29,303
Equity (m)
11,104
12,869
14,376
14,400
14,847
18,236
19,454
20,457
30,861
29,880
27,466
26,007
23,512
20,637
23,419
29,366
24,582
ROIC
16.2%
13.7%
11.2%
11.4%
14.2%
8.8%
9.6%
7.3%
9.1%
8.4%
10.0%
12.1%
11.1%
1.3%
4.7%
7.0%
4.9%
Return on capital
16.5%
15.3%
12.9%
13.2%
15.9%
10.4%
11.4%
9.7%
8.6%
8.0%
8.5%
9.8%
7.9%
1.7%
5.1%
5.3%
(1.5)%
Return on equity
18.4%
16.8%
14.0%
14.5%
18.3%
11.7%
12.6%
9.4%
13.7%
14.0%
14.8%
19.3%
16.9%
2.2%
10.9%
14.8%
(14.0)%
Plowback ratio
84.8%
82.6%
77.8%
74.1%
76.2%
63.0%
57.6%
37.9%
67.2%
62.5%
57.7%
65.4%
58.7%
(283.1)%
36.4%
59.2%
149.9%
Div.&Repurch./FCF
193.8%
56.5%
33.2%
84.1%
110.1%
68.7%
53.6%
68.3%
59.1%
41.6%
117.7%
101.0%
149.1%
81.2%
41.4%
76.6%
- -
Capital Structure
5 Jan · 2023 | Q1
All numbers in millions
Total liabilities
$ 68,293
Total assets
$ 92,875
Long-term debt
$ 29,303
Cash and equiv.
$ 2,349
Goodwill
$ 22,582
Retained earnings
$ 37,811
Common stock
864
Enterprise Value
$ 58,246
Working Capital
Currency: USD, in millions
2020
2021
2022
Cash & Investments
516
1,193
2,472
Receivables
7,132
5,663
5,017
Inventory
9,451
8,159
8,353
Other
974
1,476
1,902
Current assets
18,073
15,814
16,902
Acc. Payable
14,458
11,136
11,255
Debt due
5,965
3,565
3,345
Other
6,647
7,353
7,983
Current liabilities
27,070
22,054
22,583
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
0.15%
0.28%
7.53%
Cash flow
(48.16)%
(21.13)%
2.13%
Earnings
70.61%
104.70%
59.54%
Dividends
2.60%
(1.01)%
5.64%
Book value
25.39%
4.26%
6.28%
Insider Trading
Type
Shares
Date
Lederer John Anthony
Award
822
01/26/23
Jarrett Valerie B
Award
685
01/26/23
Murphy Dominic
Award
685
01/26/23
Ban Kevin M.
Exempt
10,303
11/18/22
Ban Kevin M.
Sale
10,303
11/18/22
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2021
36,307
32,779
34,030
34,262
137,378
2022
33,901
33,756
32,597
32,449
132,703
2023
33,382
- -
- -
- -
- -
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2021
(0.36)
1.19
1.38
0.73
2.94
2022
4.14
1.02
0.33
(1.03)
4.47
2023
(4.31)
- -
- -
- -
- -
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2021
0.47
0.47
0.47
0.47
1.87
2022
0.48
0.49
0.48
0.47
1.92
2023
0.48
- -
- -
- -
- -
Company Description
Sector:
Healthcare
Industry:
Pharmaceutical Retailers
CEO:
Mr. Stefano Pessina
Full-time employees:
325,000
City:
Deerfield
Address:
108 Wilmot Rd
IPO:
Dec 31, 2014
Walgreens Boots Alliance, Inc. operates as an integrated healthcare, pharmacy, and retailer in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides health and wellness, and specialty and home delivery pharmacy services. This segment also operates retail stores under the Walgreens and Duane Reade brands in the United States. This segment also operates retail stores under the Boots, Benavides, and Ahumada brands. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The U.S. Healthcare segment provides value-based primary care services; post-acute and home care management services; and clinical healthcare services. It also operates as a specialty pharmacy integrator and accelerator for hospitals. This segment also operates 334 VillageMD clinics, including 146 co-located clinics, 124 standalone clinics, and 64 affiliate clinics. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Recent News
· 5 Jan, 2023 · The Wall Street Journal
· 20 Sep, 2022 · The Wall Street Journal
· 11 Aug, 2022 · The Wall Street Journal
· 10 Aug, 2022 · The Wall Street Journal
· 8 Jul, 2022 · The Wall Street Journal
· 30 Jun, 2022 · The Wall Street Journal
· 4 May, 2022 · The Wall Street Journal
· 27 Apr, 2022 · The Wall Street Journal
· 6 Jan, 2022 · The Wall Street Journal
· 14 Oct, 2021 · The Wall Street Journal
· 14 Oct, 2021 · The Wall Street Journal
· 24 Sep, 2021 · The Wall Street Journal
· 15 Sep, 2021 · The Wall Street Journal